Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
New bone graft material shows promise for spine surgery
Disease control OngoingThis study tests a material called Orthoss® used during spine fusion surgery to help bones heal together. It involves 65 adults with lower back problems like slipped vertebrae or narrowed spine canal. The main goal is to see if the bones fuse properly after 6 months, and also to …
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New drug combo tested for Tough-to-Treat pancreatic cancer
Disease control OngoingThis early-stage trial is testing the safety and initial effectiveness of a new drug called GP-2250 when given with an existing chemotherapy, gemcitabine. It is for adults with advanced pancreatic cancer that has worsened after prior treatment. The main goal is to find a safe dos…
Phase: PHASE1 • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC